European Archives - Page 530 of 1198 - European Medical Journal

EMJ Cardiology 10.1 2022 Feature Image

The Future of Cardiovascular Medicine: From 2022 to 2033

In a session presented at this year’s European Society of Cardiology (ESC) Congress, which was held in-person in Barcelona, Spain, and virtually, experts discussed their future predictions for cardiovascular health and innovations that will enter this field.

ESC Interview: Nico Bruining

Nico Bruining | European Society of Cardiology (ESC) Digital Health Committee Chair; Associate Professor, Thoraxcenter, Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands

ESC Interview: Allan Böhm

Allan Böhm | Chair of the European Society of Cardiology (ESC) Committee for Young Cardiovascular Professionals; Chief Executive Officer and Founder of Premedix Clinic and Academy, Bratislava, Slovakia

EMJ Cardiology 10.1 2022 Feature Image

Cardiac Damage Staging in Patients Undergoing Transcatheter Aortic Valve Replacement: Incremental Value of Global Longitudinal Strain and Right Ventricular-Arterial Coupling

Staging cardiac damage in patients undergoing transcatheter aortic valve replacement (TAVR) has been proposed as a prognostic tool. Other authors have shown that these staging systems are related with mortality. The aim of this study was to perform an external validation of the predictive capacity of the staging system proposed by Généreux et al.

EMJ Cardiology 10.1 2022 Feature Image

Effect of Age on the Abdominal Aortic Aneurysm: Fuzzy Logic Analysis

The aneurysm refers to the increase in arterial diameter in a localised position and this is characterised by the non-parallelism of the arterial wall. Despite prediction models trying to anticipate the onset of an aneurysm, the limits of their accuracy are often reached.

EMJ Cardiology 10.1 2022 Feature Image

Referrals to Palliative Care for Cardiovascular Patients: A 10-Year Longitudinal Retrospective Study

Globally, cardiovascular diseases remain the leading cause of death, taking an estimated 17.9 million lives each year. It is projected that the global burden of cardiovascular diseases will continue to rise.

In conversation with GSK's Rino Rappuoli

This week, Helena and Isabel are honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines.

Rare Association of Takotsubo Cardiomyopathy with Acquired Bartter-Like Phenotype and Colonic Stricture

Takotsubo syndrome (TTS), also known as stress-related cardiomyopathy or apical ballooning, is a transient systolic and diastolic dysfunction that is often preceded by some physical or emotional triggers. First described in Japan in 1990, it is derived from a Japanese word meaning ‘octopus pot’.

The impact of global instability

From R&D operations to manufacturing efforts, this infographic examines how the pharma sector is being affected by current global instability due to political turmoil and soaring energy prices.

The biotech rise, fall and rebound

This infographic reflects on the evolution of the biotech sector since 2016, tracking rising revenues, investment cuts and drugs that are making it to market.